{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:40:40Z","timestamp":1787496040132,"version":"build-2736575974"},"reference-count":30,"publisher":"Archives of Endocrinology and Metabolism","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.20945\/2359-3997000000027","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T15:44:21Z","timestamp":1529509461000},"page":"221-226","source":"Crossref","is-referenced-by-count":13,"title":["TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy"],"prefix":"10.20945","volume":"62","author":[{"given":"Mira","family":"Siderova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Hristozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Tsukeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","published-online":{"date-parts":[[2018,4]]},"reference":[{"key":"key20180620154037_B1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/105072502760143791","article-title":"Mechanism of thyroid hormone action","volume":"12","author":"Harvey","year":"2002","unstructured":"1. Harvey CB, Williams GR. Mechanism of thyroid hormone action. Thyroid. 2002;12:441-6.","journal-title":"Thyroid"},{"key":"key20180620154037_B2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/BMM:2:2:135","article-title":"Effects of thyroid hormone on bone","volume":"2","author":"Stathatos","year":"2004","unstructured":"2. Stathatos N, Wartofsky L. Effects of thyroid hormone on bone. Clin Rev Bone Miner Metab. 2004;2:135-50.","journal-title":"Clin Rev Bone Miner Metab"},{"key":"key20180620154037_B3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/0004-2730000003311","article-title":"The multiple effects of thyroid disorders on bone and mineral metabolism","volume":"58","author":"Cardoso","year":"2014","unstructured":"3. Cardoso LF, Maciel LMZ, Paula FJA. The multiple effects of thyroid disorders on bone and mineral metabolism. Arq Bras Endocrinol Metabol 2014;58:452-63.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key20180620154037_B4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/JOE-12-0059","article-title":"The skeletal consequences of thyrotoxicosis","volume":"213","author":"Nicholls","year":"2012","unstructured":"4. Nicholls JJ, Brassill NJ, Williams GR, Bassett JHD. The skeletal consequences of thyrotoxicosis. J Endocrinol. 2012;213:209-21.","journal-title":"J Endocrinol"},{"key":"key20180620154037_B5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-18-7-699","article-title":"The presence of abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients","volume":"18","author":"Adams","year":"1958","unstructured":"5. Adams DD. The presence of abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J Clin Endocrinol Metab. 1958;18:699-712.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180620154037_B6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ando.2011.03.006","article-title":"Extrathyroidal expression of TSH receptor","volume":"72","author":"Williams","year":"2011","unstructured":"6. Williams GR. Extrathyroidal expression of TSH receptor. Ann Endocrinol (Paris); 2011;72:68-73.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"key20180620154037_B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","article-title":"TSH is a negative regulator of skeletal remodeling","volume":"115","author":"Abe","year":"2003","unstructured":"7. Abe E, Marians RC, Yu W, Hu XB, Ando T, Li Y, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003;115(2):151-62.","journal-title":"Cell"},{"key":"key20180620154037_B8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/thy.2010.0457","article-title":"The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis","volume":"21","author":"Ma","year":"2011","unstructured":"8. Ma R, Morshed S, Latif R, Zaidi M, Davies TF. The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis. Thyroid. 2011;21:897-906.","journal-title":"Thyroid"},{"key":"key20180620154037_B9","first-page":"4157","article-title":"Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism","volume":"85","author":"Kumeda","year":"2000","unstructured":"9. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, et al. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab. 2000;85:4157-61.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20180620154037_B10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-6614-6-11","article-title":"Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease","volume":"6","author":"Ecolano","year":"2013","unstructured":"10. Ecolano M, Drnovsek ML, Silva Croome MC, Moos M, Fuentes AM, Viale F, et al. Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease. Thyroid Res. 2013;6(1):11.","journal-title":"Thyroid Res"},{"issue":"12","key":"key20180620154037_B11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144599","article-title":"The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves' Disease","volume":"10","author":"Cho","year":"2015","unstructured":"11. Cho SW, Bae JH, Noh GW, Kim YA, Moon MK, Park KU, et al. The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves' Disease. PLoS One. 2015;10(12):e0144599.","journal-title":"PLoS One"},{"key":"key20180620154037_B12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/105072502760043503","article-title":"Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients","volume":"12","author":"Vestergaard","year":"2002","unstructured":"12. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002;12:411-9.","journal-title":"Thyroid"},{"key":"key20180620154037_B13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-13-0769","article-title":"Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women","volume":"170","author":"van Rijn","year":"2014","unstructured":"13. van Rijn LE, Pop VJ, Williams GR. Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women. Eur J Endocrinol. 2014;170:461-8.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key20180620154037_B14","first-page":"40","article-title":"Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism","volume":"64","author":"Tuchendler","year":"2013","unstructured":"14. Tuchendler D, Bolanowski M. Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism. Endokrynologia Polska. 2013;64(1):40-4.","journal-title":"Endokrynologia Polska"},{"key":"key20180620154037_B15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0954-6820.1978.tb08406.x","article-title":"A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism","volume":"204","author":"Mosekilde","year":"1978","unstructured":"15. Mosekilde L, Melsen F. A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Medica Scandinavica. 1978;204:97-102.","journal-title":"Acta Medica Scandinavica"},{"key":"key20180620154037_B16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/8756-3282(85)90218-2","article-title":"Trabecular bone remodeling and bone balance in hyperthyroidism","volume":"6","author":"Eriksen","year":"1986","unstructured":"16. Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and bone balance in hyperthyroidism. Bone. 1986;6:421-8.","journal-title":"Bone"},{"key":"key20180620154037_B17","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1590\/S0004-27302007000800028","article-title":"Glucocorticoid-Induced Osteoporosis: clinical and Therapeutic Aspects","volume":"51","author":"Mazziotti","year":"2007","unstructured":"17. Mazziotti G, Guistina A, Canalis E, Bilezikian JP. Glucocorticoid-Induced Osteoporosis: clinical and Therapeutic Aspects. Arq Bras Endocrinol Metab. 2007;51:1404-12.","journal-title":"Arq Bras Endocrinol Metab"},{"key":"key20180620154037_B18","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","unstructured":"18. Kahaly GJ, Pitz S, Hommel G, Dittmar M. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. J Clin Endocrinol Metab. 2005;90:5234-40.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180620154037_B19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.abb.2010.06.021","article-title":"Thyroid and bone","volume":"503","author":"Gogakos","year":"2010","unstructured":"19. Gogakos AI, Duncan Bassett JH, Willliams GR. Thyroid and bone. Archives of Biochemistry and Biophysics. 2010;503:129-36.","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"key20180620154037_B20","first-page":"380","article-title":"Actions of thyroid hormones in bone","volume":"60","author":"Williams","year":"2009","unstructured":"20. Williams GR. Actions of thyroid hormones in bone. Endokrynol Pol. 2009;60(5):380-8.","journal-title":"Endokrynol Pol"},{"issue":"1","key":"key20180620154037_B21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/JOE-09-0262","article-title":"TSH receptor activation and body composition","volume":"204","author":"Lloyd","year":"2010","unstructured":"21. Lloyd A, Bursell J, Gregory JW, Rees DA, Ludgate M. TSH receptor activation and body composition. J Endocrinol. 2010;204(1):13-20.","journal-title":"J Endocrinol"},{"issue":"3","key":"key20180620154037_B22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease","volume":"87","author":"Andersen","year":"2002","unstructured":"22. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002;87(3):1068-72.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20180620154037_B23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2003-031641","article-title":"Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins","volume":"89","author":"Hansen","year":"2004","unstructured":"23. Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Hegedus L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab. 2004;89(3):1181-7.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180620154037_B24","doi-asserted-by":"crossref","first-page":"638727","DOI":"10.1155\/2013\/638727","article-title":"Metabolic and clinical consequences of hyperthyroidism on bone density. Hindawi Publishing Corporation","volume":"2013","author":"Gorka","year":"2013","unstructured":"24. Gorka J, Taylor-Gjevre RM, Arnason T. Metabolic and clinical consequences of hyperthyroidism on bone density. Hindawi Publishing Corporation. Int J Endocrinol. 2013;2013:638727.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"key20180620154037_B25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00223-003-0108-3","article-title":"Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells","volume":"74","author":"Tsai","year":"2004","unstructured":"25. Tsai JA, Janson A, Bucht E, Kindmark H, Marcus C, Stark A, et al. Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells. Calcif Tissue Int. 2004;74(5):486-91.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"key20180620154037_B26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145292","article-title":"A modest protective effect of thyrotropin against bone loss is associated with plasma triiodothyronine levels","volume":"10","author":"Kim","year":"2015","unstructured":"26. Kim TH, Joung JY, Kang M, Choi SK, Kim K, Jang JY, et al. A modest protective effect of thyrotropin against bone loss is associated with plasma triiodothyronine levels. PLoS One. 2015;10(12):e0145292.","journal-title":"PLoS One"},{"issue":"10","key":"key20180620154037_B27","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1172\/JCI63948","article-title":"Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling","volume":"122","author":"Baliram","year":"2012","unstructured":"27. Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, et al. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest. 2012;122(10):3737-41.","journal-title":"J Clin Invest"},{"issue":"3","key":"key20180620154037_B28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2265.2004.02053.x","article-title":"The thyroid and the skeleton","volume":"61","author":"Murphy","year":"2004","unstructured":"28. Murphy E, Williams GR. The thyroid and the skeleton. Clin Endocrinol (Oxf). 2004;61(3):285-98.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"34","key":"key20180620154037_B29","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1073\/pnas.0600427103","article-title":"TNFalpha mediates the skeletal effects of thyroid-stimulating hormone","volume":"103","author":"Hase","year":"2006","unstructured":"29. Hase H, Ando T, Eldeiry L, Brebene A, Peng Y, Liu L, et al. TNFalpha mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci U S A. 2006;103(34):12849-54.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key20180620154037_B30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4183\/aeb.2012.47","article-title":"Evolutive particularities in thyrotoxic osteoporosis","volume":"8","author":"Haras","year":"2012","unstructured":"30. Haras M, Onose G, Capisizu A, Vulpoi C. Evolutive particularities in thyrotoxic osteoporosis. Acta Endo (Buc) 2012;8(1):47-58.","journal-title":"Acta Endo (Buc)"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T15:44:25Z","timestamp":1529509465000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972018000200221&lng=en&nrm=iso&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4]]}},"alternative-id":["10.20945\/2359-3997000000027"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000027","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}